Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Goodrx Holdings Inc Cl A (GDRX)

Goodrx Holdings Inc Cl A (GDRX)
4.40 x 80 4.61 x 20
Post-market by (Cboe BZX)
4.49 +0.04 (+0.90%) 04/17/25 [NASDAQ]
4.40 x 80 4.61 x 20
Post-market 4.49 unch (unch) 16:01 ET
Quote Overview for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
4.39
Day High
4.49
Open 4.45
Previous Close 4.45 4.45
Volume 545,700 545,700
Avg Vol 1,390,235 1,390,235
Stochastic %K 70.69% 70.69%
Weighted Alpha -35.53 -35.53
5-Day Change +0.16 (+3.82%) +0.16 (+3.82%)
52-Week Range 3.82 - 9.26 3.82 - 9.26
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,720,491
  • Shares Outstanding, K 383,610
  • Annual Sales, $ 792,320 K
  • Annual Income, $ 16,390 K
  • EBIT $ 135 M
  • EBITDA $ 207 M
  • 60-Month Beta 1.25
  • Price/Sales 2.15
  • Price/Cash Flow 13.99
  • Price/Book 2.35

Options Overview Details

View History
  • Implied Volatility 105.04% ( +8.52%)
  • Historical Volatility 60.37%
  • IV Percentile 98%
  • IV Rank 73.15%
  • IV High 130.53% on 04/04/25
  • IV Low 35.59% on 08/21/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 114
  • Volume Avg (30-Day) 197
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 21,289
  • Open Int (30-Day) 22,979

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.04
  • Number of Estimates 5
  • High Estimate 0.05
  • Low Estimate 0.03
  • Prior Year 0.03
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.82 +17.41%
on 04/07/25
Period Open: 4.46
4.95 -9.30%
on 03/20/25
+0.03 (+0.56%)
since 03/17/25
3-Month
3.82 +17.41%
on 04/07/25
Period Open: 4.57
5.43 -17.40%
on 02/27/25
-0.09 (-1.86%)
since 01/17/25
52-Week
3.82 +17.41%
on 04/07/25
Period Open: 6.50
9.26 -51.57%
on 07/25/24
-2.01 (-31.00%)
since 04/17/24

Most Recent Stories

More News
3 Healthcare Stocks with Questionable Fundamentals

3 Healthcare Stocks with Questionable Fundamentals

GDRX : 4.49 (+0.79%)
DGX : 163.80 (-0.41%)
LFST : 6.70 (-0.15%)
3 of Wall Street’s Favorite Stocks Showing Warning Signs

3 of Wall Street’s Favorite Stocks Showing Warning Signs

GDRX : 4.49 (+0.79%)
FSTR : 20.04 (+2.14%)
PLUG : 0.9003 (-2.26%)
Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers

Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers

GDRX : 4.49 (+0.79%)
HIMS : 27.23 (+1.04%)
EVH : 8.96 (-2.93%)
ASTH : 31.38 (-4.04%)
PHR : 23.97 (+0.33%)
3 Small-Cap Stocks in Hot Water

3 Small-Cap Stocks in Hot Water

GDRX : 4.49 (+0.79%)
OSK : 84.50 (+0.02%)
KIND : 1.5000 (+1.35%)
3 Stocks Under $10 Skating on Thin Ice

3 Stocks Under $10 Skating on Thin Ice

JBI : 6.41 (+5.78%)
GDRX : 4.49 (+0.79%)
DNUT : 4.15 (+4.27%)
GoodRx (GDRX) Q4 2024 Earnings Call Transcript

GDRX earnings call for the period ending December 31, 2024.

GDRX : 4.49 (+0.79%)
GoodRx (NASDAQ:GDRX) Misses Q4 Revenue Estimates

GoodRx (NASDAQ:GDRX) Misses Q4 Revenue Estimates

GDRX : 4.49 (+0.79%)
GoodRx Earnings: What To Look For From GDRX

GoodRx Earnings: What To Look For From GDRX

GDRX : 4.49 (+0.79%)
HIMS : 27.23 (+1.04%)
PINC : 19.33 (+0.05%)
This Growth Stock Is Up 150% in 6 Months. How Much Higher Can It Go?

Affirm stock has rallied spectacularly after bottoming in 2022 and is up over 150% in the last 6 months.

SHOP : 83.65 (-0.37%)
AAPL : 196.98 (+1.39%)
GDRX : 4.49 (+0.79%)
AFRM : 42.10 (+3.29%)
AMZN : 172.61 (-0.99%)
WMT : 93.22 (+2.23%)
1 Healthcare Stock Primed for Growth and 2 to Avoid

1 Healthcare Stock Primed for Growth and 2 to Avoid

GDRX : 4.49 (+0.79%)
STE : 222.23 (+1.00%)
CI : 330.13 (+0.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California.

See More

Key Turning Points

3rd Resistance Point 4.62
2nd Resistance Point 4.55
1st Resistance Point 4.52
Last Price 4.49
1st Support Level 4.42
2nd Support Level 4.36
3rd Support Level 4.32

See More

52-Week High 9.26
Fibonacci 61.8% 7.18
Fibonacci 50% 6.54
Fibonacci 38.2% 5.90
Last Price 4.49
52-Week Low 3.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro